Latest News

Combination therapy shows promise for transplanting HCV-infected organs

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe.

Source link

Related posts

U.S. Birth Rate Falls to Lowest in Decades


Domestic abuse survivors twice at risk of long-term illnesses


Uncertain Safety Rules Await Space Tourists


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy